Figure 2. The sweating threshold increased as a function of unbound plasma meperidine concentration: Sweating = 0.5[meperidine (degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 37.1, r2= 0.10. In contrast, meperidine produced a linear decrease in the core temperature triggering vasoconstriction: Vasoconstriction =-3.0[meperidine (degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 36.6, r2= 0.54. Meperidine decreased the shivering threshold nearly twice as much as the vasoconstriction threshold: Shivering =-5.6[meperidine(degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 35.6, r2= 0.62. Dashed lines indicate 95% confidence intervals. These regression slopes differ from those reported in Figure 1because they were calculated from the combined values in all volunteers rather than from individual data.

Figure 2. The sweating threshold increased as a function of unbound plasma meperidine concentration: Sweating = 0.5[meperidine (degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 37.1, r2= 0.10. In contrast, meperidine produced a linear decrease in the core temperature triggering vasoconstriction: Vasoconstriction =-3.0[meperidine (degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 36.6, r2= 0.54. Meperidine decreased the shivering threshold nearly twice as much as the vasoconstriction threshold: Shivering =-5.6[meperidine(degree Celsius [center dot] micro gram sup -1 [center dot] ml)]+ 35.6, r2= 0.62. Dashed lines indicate 95% confidence intervals. These regression slopes differ from those reported in Figure 1because they were calculated from the combined values in all volunteers rather than from individual data.

Close Modal

or Create an Account

Close Modal
Close Modal